A Jewish Psychedelic Buddhist Tells All | Jay Michaelson
Jay Michaelson, an author, journalist and rabbi whose books include The Heresy of Jacob Frank and who serves as field scholar at the Emory Center for Psychedelics and Spirituality, talks with Pinchbeck about what a second Trump administration might mean for psychedelics. Michaelson, whose Substack piece on the subject anticipated a coming pivot, notes that figures around Elon Musk and Robert F. Kennedy Jr. are hostile to FDA regulation and have flagged the rejected MDMA application for expedited review. He warns that compounds now in the pipeline are not attached to therapeutic modalities, which could open the door to off-label prescribing of the kind already routine for ketamine and Abilify. He points to rising emergency room visits in Oregon and Colorado and New York’s cannabis rollout as cautionary cases. The conversation later turns to Israel and Gaza.